Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-κB activation in endothelial cells

Tedgui, 2001, Anti-inflammatory mechanisms in the vascular wall, Circ. Res., 88, 877, 10.1161/hh0901.090440 Davies, 1993, The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis, J. Pathol., 171, 223, 10.1002/path.1711710311 Tedgui, 2006, Cytokines in atherosclerosis: pathogenic and regulatory pathways, Physiol. Rev., 86, 515, 10.1152/physrev.00024.2005 Blankenberg, 2003, Adhesion molecules and atherosclerosis, Atherosclerosis, 170, 191, 10.1016/S0021-9150(03)00097-2 Chudek, 2006, Adipose tissue, inflammation and endothelial dysfunction, Pharmacol. Rep., 58, 81 Kralisch, 2008, Secretory products from human adipocytes impair endothelial function via nuclear factor kappaB, Atherosclerosis, 196, 523, 10.1016/j.atherosclerosis.2007.05.016 Kougias, 2005, Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease, J. Surg. Res., 126, 121, 10.1016/j.jss.2004.12.023 Fukuhara, 2005, Visfatin: a protein secreted by visceral fat that mimics the effects of insulin, Science, 307, 426, 10.1126/science.1097243 Moschen, 2007, Visfatin, an adipocytokine with proinflammatory and immunomodulating properties, J. Immunol., 178, 1748, 10.4049/jimmunol.178.3.1748 Jia, 2004, Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis, J. Clin. Invest., 113, 1318, 10.1172/JCI19930 Kim, 2007, Visfatin promotes angiogenesis by activation of extracellular signal-regulated kinase 1/2, Biochem. Biophys. Res. Commun., 357, 150, 10.1016/j.bbrc.2007.03.105 Guzik, 2006, Adipocytokines — novel link between inflammation and vascular function?, J. Physiol. Pharmacol., 57, 505 Carmeliet, 2003, Angiogenesis in health and disease, Nat. Med., 9, 653, 10.1038/nm0603-653 Pugin, 1993, Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14, Proc. Natl. Acad. Sci. U. S. A., 90, 2744, 10.1073/pnas.90.7.2744 Zeuke, 2002, TLR4-mediated inflammatory activation of human coronary artery endothelial cells by LPS, Cardiovasc. Res., 56, 126, 10.1016/S0008-6363(02)00512-6 Wang, 2002, Increased monocyte adhesion to aortic endothelium in rats with hyperhomocysteinemia: role of chemokine and adhesion molecules, Arterioscler. Thromb. Vasc. Biol., 22, 1777, 10.1161/01.ATV.0000035404.18281.37 Min, 2005, TNF-related activation-induced cytokine enhances leukocyte adhesiveness: induction of ICAM-1 and VCAM-1 via TNF receptor-associated factor and protein kinase C-dependent NF-kappaB activation in endothelial cells, J. Immunol., 175, 531, 10.4049/jimmunol.175.1.531 Neish, 1992, Functional analysis of the human vascular cell adhesion molecule 1 promoter, J. Exp. Med., 176, 1583, 10.1084/jem.176.6.1583 Zimmerman, 2002, Superoxide mediates the actions of angiotensin II in the central nervous system, Circ. Res., 91, 1038, 10.1161/01.RES.0000043501.47934.FA Griendling, 1994, Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells, Circ. Res., 74, 1141, 10.1161/01.RES.74.6.1141 Brentano, 2007, Pre-B cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities, Arthritis Rheum., 56, 2829, 10.1002/art.22833 Dahl, 2007, Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization, Circulation, 115, 972, 10.1161/CIRCULATIONAHA.106.665893 Liu, 2006, NF-kappa B activation as a pathological mechanism of septic shock and inflammation, Am. J. Physiol., Lung Cell. Mol. Physiol., 290, L622, 10.1152/ajplung.00477.2005 Minami, 2001, Thrombin stimulation of the vascular cell adhesion molecule-1 promoter in endothelial cells is mediated by tandem nuclear factor-kappa B and GATA motifs, J. Biol. Chem., 276, 47632, 10.1074/jbc.M108363200 Bessho, 1994, Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor kappa B (NF-kappa B) activation, prevents apoptosis in human promyelocytic leukemia HL-60 cells and thymocytes, Biochem. Pharmacol., 48, 1883, 10.1016/0006-2952(94)90586-X Beinke, 2004, Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology, Biochem. J., 382, 393, 10.1042/BJ20040544 Droge, 2002, Free radicals in the physiological control of cell function, Physiol. Rev., 82, 47, 10.1152/physrev.00018.2001 Griendling, 2000, Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology, Arterioscler. Thromb. Vasc. Biol., 20, 2175, 10.1161/01.ATV.20.10.2175 Kunsch, 1999, Oxidative stress as a regulator of gene expression in the vasculature, Circ. Res., 85, 753, 10.1161/01.RES.85.8.753 Schreck, 1991, Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1, EMBO J., 10, 2247, 10.1002/j.1460-2075.1991.tb07761.x Van Gaal, 2006, Mechanisms linking obesity with cardiovascular disease, Nature, 444, 875, 10.1038/nature05487 Shirai, 2004, Obesity as the core of the metabolic syndrome and the management of coronary heart disease, Curr. Med. Res. Opin., 20, 295, 10.1185/030079903125003008 Libby, 2002, Inflammation and atherosclerosis, Circulation, 105, 1135, 10.1161/hc0902.104353 Cooke, 2002, Does leptin cause vascular disease?, Circulation, 106, 1904, 10.1161/01.CIR.0000036864.14101.1B Kougias, 2005, Adipocyte-derived cytokine resistin causes endothelial dysfunction of porcine coronary arteries, J. Vasc. Surg., 41, 691, 10.1016/j.jvs.2004.12.046 Lau, 2005, Adipokines: molecular links between obesity and atherosclerosis, Am. J. Physiol, Heart Circ. Physiol., 288, H2031, 10.1152/ajpheart.01058.2004 Beltowski, 2006, Role of leptin in blood pressure regulation and arterial hypertension, J. Hypertens., 24, 789, 10.1097/01.hjh.0000222743.06584.66 Yamagishi, 2001, Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A, J. Biol. Chem., 276, 25096, 10.1074/jbc.M007383200 Kjerrulf, 2006, Reduced cholesterol accumulation by leptin deficient (ob/ob) mouse macrophages, Inflamm. Res., 55, 300, 10.1007/s00011-006-0087-8 Barnes, 1997, Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases, N. Engl. J. Med., 336, 1066, 10.1056/NEJM199704103361506 Csiszar, 2006, Resveratrol attenuates TNF-alpha-induced activation of coronary arterial endothelial cells: role of NF-kappaB inhibition, Am. J. Physiol, Heart Circ. Physiol., 291, H1694, 10.1152/ajpheart.00340.2006 Sizemore, 1999, Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit, Mol. Cell. Biol., 19, 4798, 10.1128/MCB.19.7.4798 Madrid, 2001, Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-kappa B through utilization of the ikappa B kinase and activation of the mitogen-activated protein kinase p38, J. Biol. Chem., 276, 18934, 10.1074/jbc.M101103200 Stephens, 2006, An update on visfatin/pre-B cell colony-enhancing factor, an ubiquitously expressed, illusive cytokine that is regulated in obesity, Curr. Opin. Lipidol., 17, 128, 10.1097/01.mol.0000217893.77746.4b Saperstein, 1989, Design of a selective insulin receptor tyrosine kinase inhibitor and its effect on glucose uptake and metabolism in intact cells, Biochemistry, 28, 5694, 10.1021/bi00439a053 Lum, 2001, Oxidant stress and endothelial cell dysfunction, Am. J. Physiol., Cell Physiol., 280, C719, 10.1152/ajpcell.2001.280.4.C719 Fortuno, 2005, Oxidative stress and vascular remodelling, Exp. Physiol., 90, 457, 10.1113/expphysiol.2005.030098 Griendling, 2000, NAD(P)H oxidase: role in cardiovascular biology and disease, Circ. Res., 86, 494, 10.1161/01.RES.86.5.494 Sorescu, 2001, NAD(P)H oxidases and their relevance to atherosclerosis, Trends Cardiovasc. Med., 11, 124, 10.1016/S1050-1738(01)00097-4